179 related articles for article (PubMed ID: 12046684)
1. Allogeneic hematopoietic cell transplantation for multiple myeloma.
Bensinger WI
Biomed Pharmacother; 2002 May; 56(3):133-8. PubMed ID: 12046684
[TBL] [Abstract][Full Text] [Related]
2. The current status of hematopoietic stem cell transplantation for multiple myeloma.
Bensinger WI
Clin Adv Hematol Oncol; 2004 Jan; 2(1):46-52. PubMed ID: 16163159
[TBL] [Abstract][Full Text] [Related]
3. The current status of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma.
Bensinger WI
Leukemia; 2006 Oct; 20(10):1683-9. PubMed ID: 16888617
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic cell transplantation for multiple myeloma.
Bensinger WI; Maloney D; Storb R
Semin Hematol; 2001 Jul; 38(3):243-9. PubMed ID: 11486312
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in hematopoietic stem cell transplantation for multiple myeloma.
Bensinger WI
Int J Hematol; 2003 Apr; 77(3):232-8. PubMed ID: 12731665
[TBL] [Abstract][Full Text] [Related]
6. The role of hematopoietic stem cell transplantation in the treatment of multiple myeloma.
Bensinger WI
J Natl Compr Canc Netw; 2004 Jul; 2(4):371-8. PubMed ID: 19795599
[TBL] [Abstract][Full Text] [Related]
7. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
[TBL] [Abstract][Full Text] [Related]
8. Is there still a role for allogeneic stem-cell transplantation in multiple myeloma?
Bensinger WI
Best Pract Res Clin Haematol; 2007 Dec; 20(4):783-95. PubMed ID: 18070719
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma: role of allogeneic transplantation.
Pandit S; Vesole DH
Oncology (Williston Park); 2002 Sep; 16(9):1268-74; discussion 1274-6. PubMed ID: 12380950
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma.
Reynolds C; Ratanatharathorn V; Adams P; Braun T; Silver S; Ayash L; Carson E; Eisbruch A; Dawson LA; McDonagh K; Ferrara J; Uberti J
Bone Marrow Transplant; 2001 Apr; 27(8):801-7. PubMed ID: 11477436
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
12. Role of reduced intensity conditioning in allogeneic hematopoietic cell transplantation for patients with multiple myeloma.
Nishihori T; Kharfan-Dabaja MA; Ochoa-Bayona JL; Bazarbachi A; Pasquini M; Alsina M
Hematol Oncol Stem Cell Ther; 2011; 4(1):1-9. PubMed ID: 21460601
[TBL] [Abstract][Full Text] [Related]
13. Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo Clinic.
Mir MA; Kapoor P; Kumar S; Pandey S; Dispenzieri A; Lacy MQ; Dingli D; Hogan W; Buadi F; Hayman S; Gandhi M; Gertz MA
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):349-357.e2. PubMed ID: 25958193
[TBL] [Abstract][Full Text] [Related]
14. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
Kyle RA
Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
[TBL] [Abstract][Full Text] [Related]
15. Advances in the autologous and allogeneic transplantation strategies for multiple myeloma.
Nishihori T; Alsina M
Cancer Control; 2011 Oct; 18(4):258-67. PubMed ID: 21976244
[TBL] [Abstract][Full Text] [Related]
16. Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.
Björkstrand B; Iacobelli S; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Musto P; Beksac M; Bosi A; Milone G; Corradini P; Goldschmidt H; de Witte T; Morris C; Niederwieser D; Gahrton G
J Clin Oncol; 2011 Aug; 29(22):3016-22. PubMed ID: 21730266
[TBL] [Abstract][Full Text] [Related]
17. Role of autologous and allogeneic stem cell transplantation in myeloma.
Bensinger WI
Leukemia; 2009 Mar; 23(3):442-8. PubMed ID: 19277049
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic hematopoietic stem cell transplantation for multiple myeloma: curative but not the standard of care.
Koehne G; Giralt S
Curr Opin Oncol; 2012 Nov; 24(6):720-6. PubMed ID: 22960558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
